AHMED NADIM 4
4 · Cullinan Oncology, Inc. · Filed Dec 27, 2023
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-12-26$9.24/sh−4,272$39,473→ 111,550 total
Footnotes (1)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.